4.6 Review

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy

Related references

Note: Only part of the references are listed.
Article Oncology

Baseline Interleukin-6 and-8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

Osman Oecal et al.

Summary: Baseline IL-6 and IL-8 values were found to predict outcomes in sorafenib-treated HCC patients, suggesting potential for guiding patient selection and improving treatment outcomes.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Microbiology

Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation

Avdhesh Kumar Rai et al.

Summary: Advanced combinatorial treatments of surgery, chemotherapy, and radiotherapy have no effect on the 5-year survival rate of oral squamous cell carcinoma (OSCC). Early diagnostic non-invasive biomarkers are needed to improve the survival rate of OSCC patients. Recent research suggests that the oral microbiome plays a significant role in the development of OSCC through inducing an inflammatory response via production of cytokines and chemokines that enhance tumor cell proliferation and survival. The study aims to develop a saliva-based biomarker panel using oral microbiome and cytokine levels for screening OSCC patients, showing potential for more efficient screening and early detection.

ARCHIVES OF MICROBIOLOGY (2021)

Article Pathology

Overexpression of IL-8 promotes cell migration via PI3K-Akt signaling pathway and EMT in triple-negative breast cancer

Fang Deng et al.

Summary: IL-8 plays a crucial role in the progression of TNBC, promoting tumor cell migration and growth, affecting cell cycle, and influencing the expression of certain cell cycle proteins.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Review Pharmacology & Pharmacy

Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression

Kristen Fousek et al.

Summary: IL-8 plays a significant role in the tumor microenvironment by affecting tumor cell proliferation, invasiveness, drug resistance, and immune cell killing capacity, thereby impacting the efficacy of immunotherapy.

PHARMACOLOGY & THERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel

Elke Kaemmerer et al.

Summary: This article reviews the composition of the tumour microenvironment, including the ECM and different elements contributing to drug resistance. It discusses approaches for modelling the TME, current progress, and their use in low and high-throughput assays for preclinical studies, summarising the status quo of advanced 3D cancer models compatible with high throughput screening and the technical practicalities and challenges.

DRUG DISCOVERY TODAY (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch et al.

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

Article Oncology

Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma

Qianfei Zhang et al.

Summary: The study demonstrates that gut dysbiosis can lead to the accumulation of PMN-MDSCs, promoting liver cancer development. However, treatment with neomycin can block this process and inhibit tumor growth, even in the absence of liver disease or colitis.

CANCER DISCOVERY (2021)

Review Cell Biology

Unexpected guests in the tumor microenvironment: microbiome in cancer

Abigail Wong-Rolle et al.

Summary: The local microbiota play a significant role in the tumor microenvironment across various types of cancer, particularly in cancers originating from mucosal sites like the lung, skin, and gastrointestinal tract. The populations of bacteria specific to tumors have been found to be tumor-type specific and may directly regulate cancer initiation, progression, and responses to treatments.

PROTEIN & CELL (2021)

Article Biochemistry & Molecular Biology

The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function

Ruth M. Urbantat et al.

Summary: The study found that in glioblastoma, the overexpression of VEGF and CXCL2 was associated with decreased patient survival. However, while there were correlations among molecules in the VEGF pathway, no significant relationship was found between CXCR1/2 and CXCL2/IL8. Brain endothelial cells reacted differently to various proangiogenic molecules compared to peripheral endothelial cells, and treatment with a CXCR2 antagonist reduced endothelial cell motility and sprouting.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Escin inhibits angiogenesis by suppressing interleukin-8 and vascular endothelial growth factor production by blocking nuclear factor-κB activation in pancreatic cancer cell lines

Kan Omi et al.

Summary: The study confirmed that escin inhibits angiogenesis in pancreatic cancer by reducing the secretion of IL-8 and VEGF through blocking NF-kappa B activity. This suggests that escin could be a novel molecular therapy for pancreatic cancer.

ONCOLOGY REPORTS (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients

Diwakar Davar et al.

Summary: The study demonstrated that fecal microbiota transplantation combined with anti-PD-1 therapy can overcome resistance to anti-PD-1 in a subset of PD-1 refractory melanoma patients, leading to clinical benefits. This approach induced changes in the gut microbiome and reprogrammed the tumor microenvironment, ultimately enhancing the efficacy of anti-PD-1 treatment.

SCIENCE (2021)

Review Immunology

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes

Samuel I. Kim et al.

Summary: Cancer immunotherapy has revolutionized treatment in oncology, but its effectiveness varies among patients. Biomarkers predicting response include factors like tumor size and tumor burden. Therapeutic approaches for larger tumors involve reducing tumor burden and modulating the immune microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

Sofia Koustoulidou et al.

Summary: Cancer Associated Fibroblasts (CAFs) are a crucial component of the tumor microenvironment with complex origins and diverse functions, making them an appealing target for novel therapeutic interventions in cancer. Despite some limitations in translating CAF-targeting interventions from research to clinical use, promising developments have been made, particularly in targeting Fibroblast Activation Protein (FAP) on CAFs for improved cancer diagnosis and treatment.

CANCERS (2021)

Review Oncology

Underlying mechanisms and drug intervention strategies for the tumour microenvironment

Haoze Li et al.

Summary: The tumor microenvironment (TME) plays a significant role in cancer development, characterized by a complex system and biological features including hypoxia, nutrient deficiency, inflammation, immunosuppression, etc. Studying the role of TME in cancer progression and intervention strategies provides a scientific basis for cancer therapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin

Yuan Cheng et al.

Summary: Inhibition of CXCR2 has therapeutic effects in lung cancer by promoting apoptosis, senescence, EMT, and anti-proliferation of cancer cells, reducing infiltration of tumor-associated neutrophils, enhancing anti-tumor T cell activity, and increasing sensitivity to chemotherapeutic agents.

MOLECULAR CANCER (2021)

Review Biochemistry & Molecular Biology

Multimodal Functional Imaging for Cancer/Tumor Microenvironments Based on MRI, EPRI, and PET

Ken-ichiro Matsumoto et al.

Summary: Radiation therapy is a crucial treatment for cancer and tumors, but its efficacy can be affected by physiological and/or pathological conditions in the target tissues, such as low oxygen pressure and altered redox status. Various imaging techniques can visualize the pathophysiological microenvironment of cancer/tumor tissues, aiding in treatment planning and early detection. Accurate co-registration of multimodal images can help clarify drug mechanisms and biological effects.

MOLECULES (2021)

Article Multidisciplinary Sciences

Cell-programmed nutrient partitioning in the tumour microenvironment

Bradley Reinfeld et al.

Summary: The study found that in the tumor microenvironment, different cell types have varying abilities to access and consume glucose and glutamine, with nutrient partitioning being programmed in a cell-intrinsic manner through mTORC1 signaling and the expression of genes related to glucose and glutamine metabolism.

NATURE (2021)

Review Biotechnology & Applied Microbiology

Navigating CAR-T cells through the solid-tumour microenvironment

Andrew J. Hou et al.

Summary: CAR-T cells have limited efficacy in treating solid tumors, but various engineering strategies can overcome the obstacles posed by the tumor microenvironment, producing next-generation T cells with enhanced specificity and sustained effector function.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Oncology

Persistent Inflammatory Stimulation Drives the Conversion of MSCs to Inflammatory CAFs That Promote Pro-Metastatic Characteristics in Breast Cancer Cells

Linor Rubinstein-Achiasaf et al.

Summary: In breast cancer progression, chronic inflammation can induce the conversion of mesenchymal stem cells (MSCs) to inflammatory cancer-associated fibroblasts (CAFs). These inflammation-driven CAFs secrete metastasis-promoting factors that enhance the dispersion and migration of breast cancer cells. The findings suggest that targeting pro-inflammatory mediators could lead to lower levels of pro-metastatic CAFs in breast tumors.

CANCERS (2021)

Article Biology

Interleukin-6 and Interleukin-8 Regulate STAT3 Activation Migration/Invasion and EMT in Chrysophanol-Treated Oral Cancer Cell Lines

Po-Chih Hsu et al.

Summary: Chrysophanol has been found to inhibit migration, invasion, and epithelial-mesenchymal transition of oral cancer cells, as well as reduce the expression of IL-6 and IL-8, leading to decreased invasion ability. Additionally, it attenuates EMT by increasing E-cadherin expression and decreasing vimentin expression, and inhibits IL-6- and IL-8-induced invasion and STAT3 phosphorylation. This suggests a potential therapeutic role of chrysophanol in oral cancer through targeting the tumor microenvironment and cytokine signaling pathways.

LIFE-BASEL (2021)

Article Oncology

Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

Colin Hutton et al.

Summary: This study used mass cytometry to analyze the stromal composition in murine tissues and tumors, revealing extensive stromal heterogeneity and coordinated relationships between mesenchymal and immune cell subsets in pancreatic ductal adenocarcinoma. The research identified two stable and functionally distinct pancreatic fibroblast lineages marked by CD105 expression, with CD105-positive fibroblasts promoting tumor growth and CD105-negative fibroblasts suppressing tumors, dependent on adaptive immunity. These findings highlight the importance of mesenchymal and immune cell interactions in restricting tumor growth.

CANCER CELL (2021)

Article Immunology

Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin

Gang Nie et al.

Summary: Breast cancer stem cells and tumor-associated macrophages play crucial roles in breast cancer growth and metastasis. High CXCL8 expression is significantly associated with metastasis and tumor growth in breast cancer patients. Danirixin effectively reduces tumor growth, metastasis, and suppresses self-renewal of stem cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Oncology

Cancer: a mirrored room between tumor bulk and tumor microenvironment

Pablo Hernandez-Camarero et al.

Summary: The tumor microenvironment plays a crucial role in promoting drug resistance, tumor progression, metastasis, and maintaining a cancer stem-like phenotype. Different groups of stromal cells in the TME have specific spatial distributions that evolve as the tumor progresses. Understanding the interaction between TME and metastasis is essential for improving cancer clinical management.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8

Carlos E. de Andrea et al.

Summary: NETs are present in various human solid tumors and are associated with IL-8 protein expression and CD8(+) T-cell density in the tumor microenvironment. There is individual variation in NET density across different cancer types, with a positive correlation with IL-8 and a trend towards a negative association with CD8(+) TILs.

JOURNAL OF PATHOLOGY (2021)

Review Oncology

Clinical and therapeutic relevance of cancer-associated fibroblasts

Yang Chen et al.

Summary: CAFs, as highly versatile and resilient cells in primary and metastatic tumors, play crucial roles in cancer progression through complex interactions with other cell types in the tumor microenvironment. Their heterogeneity and dynamic interactions are key factors in cancer development.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer

Wenyu Wang et al.

Summary: The study reveals that in colorectal cancer, cancer-associated fibroblast-activated stromal signaling induces BRD4 phosphorylation, leading to resistance to BET inhibitors. Inhibiting IL6/IL8-JAK2 signaling eliminates BRD4 phosphorylation, sensitizing BET inhibitors against cancer cells.

NATURE COMMUNICATIONS (2021)

Review Oncology

The Role of Neutrophil Extracellular Traps in Cancer

Bo-Zong Shao et al.

Summary: Neutrophil extracellular traps (NETs) play a vital role in the immune response, combating microbial infections and influencing the pathogenesis of various diseases. This review highlights the biological characteristics of NETs and their mechanisms in cancer, providing insights into potential therapeutic targets.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma

Xiaobei Liu et al.

Summary: CXCR2 and CXCL8 were found to predict poor prognosis in NPC patients, and treatment with CXCR2 antagonist SB225002 resulted in inhibition of tumorigenesis in nasopharyngeal carcinoma cell lines, as well as enhancing radiosensitivity. Additionally, SB225002 reduced microvessel density, proliferation, and tumor-associated neutrophils in the tumors, suggesting it as a promising therapeutic strategy for NPC treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling

Zhaodong Ji et al.

Summary: IL-8 secreted by cancer-associated fibroblasts and cancer cells promotes stemness in human ovarian cancer via the activation of Notch3-mediated signaling, providing a potential novel strategy for ovarian cancer treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Multidisciplinary Sciences

Nanotechnology-enhanced immunotherapy for metastatic cancer

Peisen Zhang et al.

Summary: Nanotechnology shows promising potential in improving immunotherapeutic outcomes for patients with metastatic cancer by selectively triggering specific tumoricidal effects, enhancing immune cell access to major sites of metastasis, and inducing a persistent immune response.

INNOVATION (2021)

Article Biochemistry & Molecular Biology

Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production

Kazuki Kai et al.

Summary: It was found that oral squamous cell carcinoma cells promote the differentiation of monocytes into CD206(+) TAMs through the production of PAI-1 and IL-8. Positive correlations were observed among CD206(+), PAI-1(+), and IL-8(+) cells in OSCC sections.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

Fanglong Wu et al.

Summary: CAFs play vital roles in cancer progression and their complex signaling pathways with cancer cells are crucial for understanding the development of cancer.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Interleukins in cancer: from biology to therapy

Dania Briukhovetska et al.

Summary: This article provides an update on the role of interleukins in tumor biology, highlighting their significance in cancer development, progression, and immunotherapy. Interleukins can both promote cancer growth and enhance tumor-directed immune responses, making them a valuable target for improving treatment effectiveness and reducing side effects.

NATURE REVIEWS CANCER (2021)

Article Oncology

Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity

Jinming Yang et al.

Summary: The inhibition of the CXCR2 signaling pathway can reduce the number of MDSC in the tumor microenvironment, increase CXCL11-expressing B1b cells, and subsequently promote the infiltration and activation of effector CD8(+) T cells in tumors.

CANCER IMMUNOLOGY RESEARCH (2021)

Review Oncology

Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins

Cedric Zeltz et al.

SEMINARS IN CANCER BIOLOGY (2020)

Review Cell Biology

Cytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatment

Ghasem Rahimi Kalateh Shah Mohammad et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Article Oncology

Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment

Erin Helms et al.

Cancer Discovery (2020)

Review Biotechnology & Applied Microbiology

Significance of the IL-8 pathway for immunotherapy

Manuela Gonzalez-Aparicio et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy

Bernardo L. Rapoport et al.

MOLECULES (2020)

Article Biochemistry & Molecular Biology

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe C. Yuen et al.

NATURE MEDICINE (2020)

Review Oncology

Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways

Go J. Yoshida

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Multidisciplinary Sciences

The gut microbiota is associated with immune cell dynamics in humans

Jonas Schluter et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells

Sangmin Kim et al.

CYTOKINE (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Review Multidisciplinary Sciences

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers

Zhihao Lu et al.

INNOVATION (2020)

Review Biochemistry & Molecular Biology

The updated landscape of tumor microenvironment and drug repurposing

Ming-Zhu Jin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

Tumour-intrinsic resistance to immune checkpoint blockade

Anusha Kalbasi et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Commensal Microbiota Promote Lung Cancer Development via γδ T Cells

Chengcheng Jin et al.

Review Biochemistry & Molecular Biology

The microbiome, cancer, and cancer therapy

Beth A. Helmink et al.

NATURE MEDICINE (2019)

Review Oncology

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells

Pier Adelchi Ruffini

FRONTIERS IN ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

The pros, cons, and many unknowns of probiotics

Jotham Suez et al.

NATURE MEDICINE (2019)

Article Oncology

Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma

Fengkai Sun et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Oncology

Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway

Yiwei Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Article Multidisciplinary Sciences

CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors

Linchun Jin et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Fecal microbiota transplantation in cancer management: Current status and perspectives

Danfeng Chen et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Biochemistry & Molecular Biology

IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway

Tingjin Zheng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers

Jin Won Yang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Review Biochemistry & Molecular Biology

Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

Divya Thomas et al.

MOLECULAR CANCER (2019)

Review Biotechnology & Applied Microbiology

Turning foes to friends: targeting cancer-associated fibroblasts

Xueman Chen et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Biotechnology & Applied Microbiology

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Jerome Galon et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Review Gastroenterology & Hepatology

Alcohol, liver disease and the gut microbiota

Jasmohan S. Bajaj

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Medicine, Research & Experimental

Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC

Julia Kargl et al.

JCI INSIGHT (2019)

Review Oncology

The Gut-Brain Axis, Paving the Way to Brain Cancer

Ruty Mehrian-Shai et al.

TRENDS IN CANCER (2019)

Article Medicine, Research & Experimental

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun et al.

JCI INSIGHT (2019)

Article Biochemistry & Molecular Biology

ShRNA-mediated knock-down of CXCL8 inhibits tumor growth in colorectal liver metastasis

Abhishek Kumar et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling

Yingxia Ning et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Gastroenterology & Hepatology

Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response

Vrishketan Sethi et al.

GASTROENTEROLOGY (2018)

Review Biochemistry & Molecular Biology

Understanding the tumor immune microenvironment (TIME) for effective therapy

Mikhail Binnewies et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Extensive impact of non-antibiotic drugs on human gut bacteria

Lisa Maier et al.

NATURE (2018)

Article Biotechnology & Applied Microbiology

IL-8 regulates the sternness properties of cancer stern cells in the small-cell lung cancer cell line H446

Fang Jin et al.

ONCOTARGETS AND THERAPY (2018)

Article Oncology

Inflammatory cytokine IL-8/CXCL8 promotes tumour escape from hepatocyte-induced dormancy

Ahmad S. Khazali et al.

BRITISH JOURNAL OF CANCER (2018)

Article Dentistry, Oral Surgery & Medicine

Microbial and inflammatory-based salivary biomarkers of head and neck squamous cell carcinoma

Anna Vesty et al.

CLINICAL AND EXPERIMENTAL DENTAL RESEARCH (2018)

Article Pharmacology & Pharmacy

Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2

Jakob Busch-Petersen et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Multidisciplinary Sciences

Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration

Hasini Jayatilaka et al.

NATURE COMMUNICATIONS (2017)

Review Medicine, Research & Experimental

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

Helen Ha et al.

THERANOSTICS (2017)

Article Medicine, Research & Experimental

Tumor Microenvironment and Differential Responses to Therapy

Eishu Hirata et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

Review Oncology

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Carlos Alfaro et al.

CANCER TREATMENT REVIEWS (2017)

Review Immunology

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy

Nisha Nagarsheth et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Biochemistry & Molecular Biology

IL-8 interacts with metadherin promoting proliferation and migration in gastric cancer

Wenfeng Li et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

The CXCL8-CXCR1/2 pathways in cancer

Qian Liu et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

Article Multidisciplinary Sciences

Tumor-associated fibroblasts predominantly come from local and not circulating precursors

Ainhoa Arina et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Xiaoyong Fu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Review Immunology

The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance

Justin M. David et al.

VACCINES (2016)

Article Oncology

CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin

Xiu-guo Han et al.

CANCER LETTERS (2015)

Review Immunology

Immunological hallmarks of stromal cells in the tumour microenvironment

Shannon J. Turley et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Pharmacology & Pharmacy

Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist

David J. Nicholls et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)

Review Immunology

Fibroblast heterogeneity in the cancer wound

Daniel Oehlund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Article Cell Biology

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

Steven L. Highfill et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

Article Biochemistry & Molecular Biology

EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway

R. Bonavia et al.

ONCOGENE (2012)

Review Cell Biology

Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy

Pravin Mishra et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2011)

Article Oncology

CXC Receptor-1 Silencing Inhibits Androgen-Independent Prostate Cancer

Nagarajarao Shamaladevi et al.

CANCER RESEARCH (2009)

Article Multidisciplinary Sciences

Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network

Arturo V. Orjalo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury

R Bertini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)